Chris Labaki
@Chrislabaki1
PGY-2 @BIDMC_IM | Research Associate @DanaFarber | via @DanaFarber @USJLiban
Extremely excited and over the moon to have matched @BIDMC_IM @harvardmed !!! This would not have been possible without the incredible support of my exceptional mentors @DrChoueiri @VanAllenLab @BraunMDPhD Missing my parents.
Powerful words @CJSTRAV3 about the importance of research funding and continuous efforts, with the goal of improving patient outcomes @kidneycan #KCRS25
Great talk by @VincentWenxinXu regarding the major role of KIM-1 in guiding therapeutic decision-making in #RCC @kidneycan #KCRS25
Bryan Lewis @kidneycan with a moving and touching speech at the opening ceremony of #KCRS25
And we're off! #KCRS25 begins with an important session on variant histologies of RCC, with @BradMcG04 giving an overview of papillary RCC @KidneyCancer
Chromophobe renal cell carcinoma is difficult to treat - Research in @JCO_ASCO provides better understanding of this rare kidney cancer, potential treatment pathways & immunotherapy strategies. @DanaFarber_GU @eddy_saad @Chrislabaki1 @BIDMChealth ➡️ bit.ly/3IhLT8d
Novel Insights into Chromophobe Renal Cell Carcinoma Biology and Potential Therapeutic Strategies @BraunMDPhD @YaleCancer #KidneyCancer onclive.com/view/novel-ins…
Lucky to be part of such an exceptional group with the leadership/mentorship of @BraunMDPhD Working towards better outcomes for patients with kidney cancer
1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immunobiology: Can we use machine-learning approaches to classify RCC and predict response? @Cancer_Cell What drives exceptional response with immunotherapies?…
Great work from @Chrislabaki1 @BIDMChealth , led with @eddy_saad and #KatrineMadsen. Large team effort led together with @LisaHenske @BrighamWomens @ShuklaSachet @MDAndersonNews and @VanAllenLab and @DrChoueiri @DanaFarber @kidneycan @KidneyCancer @kidneycoa @OncLive
A rare #kidneycancer, chromophobe RCC, resists traditional immunotherapy because of its ability to hide from the immune system. A @YaleCancer-led study in @JCO_ASCO reveals the tumor’s unique biology and urgent need for new treatment strategies. yalecancercenter.org/news-article/n……